AlphaYouDFTX: Sullivan Mark discloses a sale
By AlphaYouPublished Form 4
Sullivan Mark
Reporting filer
Sullivan Mark reported Sale in Definium Therapeutics, Inc.: 14051 units of Common Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 30, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Sullivan Mark | 2026-09-25 | S | Sale | 14051 | 36.57 | 494,228 | 5 days | Filed terms
|
Common Shares
- Owner
- Sullivan Mark
- Date
- 2026-09-25
- Code
- S
- Action
- Sale
- Quantity
- 14051
- Price
- 36.57
- Following holdings
- 494,228
- Reporting delay
- 5 days
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-09-25
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Timeliness:
- transaction Shares: 14051
- transaction Price Per Share: 36.57
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 494228
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sullivan Mark: Chief Legal Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections under a Rule 10b5-1 plan adopted on March 14, 2024.
- F2: The reported price is a weighted average sales price. These shares were sold in multiple transactions on September 25, 2026 at prices ranging from $36.24 to $36.98. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Original sources
Prepared automatically from public filing data. Report a correction.